S&P 500   4,471.37
DOW   35,294.76
QQQ   368.94
S&P 500   4,471.37
DOW   35,294.76
QQQ   368.94
S&P 500   4,471.37
DOW   35,294.76
QQQ   368.94
S&P 500   4,471.37
DOW   35,294.76
QQQ   368.94

Absci Stock Forecast, Price & News

+0.04 (+0.38 %)
(As of 10/15/2021 04:00 PM ET)
Today's Range
50-Day Range
52-Week Range
Volume62,721 shs
Average Volume340,885 shs
Market Capitalization$983.88 million
P/E RatioN/A
Dividend YieldN/A
30 days | 90 days | 365 days | Advanced Chart
Receive ABSI News and Ratings via Email

Sign-up to receive the latest news and ratings for Absci and its competitors with MarketBeat's FREE daily newsletter.

Absci logo

About Absci

Absci Corporation is the AI-powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. The company's Creation(TM) Platform involved in discovery of novel biotherapeutic drug candidates and generation of the cell lines to manufacture them in a single efficient process. Absci Corporation is based in VANCOUVER, Wash.


Absci (NASDAQ:ABSI) Shares Up 4%
October 15, 2021 |  americanbankingnews.com
Absci (NASDAQ:ABSI) Shares Gap Up to $10.01
October 13, 2021 |  americanbankingnews.com
Absci (NASDAQ:ABSI) Reaches New 52-Week Low at $10.15
October 8, 2021 |  americanbankingnews.com
Absci (NASDAQ:ABSI) Trading Up 3.1%
October 6, 2021 |  americanbankingnews.com
Absci (NASDAQ:ABSI) Shares Gap Up to $10.88
October 5, 2021 |  americanbankingnews.com
Absci (NASDAQ:ABSI) Stock Price Down 9.4%
October 4, 2021 |  americanbankingnews.com
See More Headlines

Industry, Sector and Symbol

Commercial physical research
Current Symbol
Year Founded

Sales & Book Value

Annual Sales
$4.78 million





Market Cap
$983.88 million
Next Earnings Date
11/9/2021 (Confirmed)
Not Optionable


Overall MarketRank

1.74 out of 5 stars

Medical Sector

859th out of 1,361 stocks

Commercial Physical Research Industry

14th out of 26 stocks

Analyst Opinion: 4.2Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.6 5 -4 -3 -2 -1 -

Absci (NASDAQ:ABSI) Frequently Asked Questions

Is Absci a buy right now?

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Absci in the last year. There are currently 4 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" Absci stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in ABSI, but not buy additional shares or sell existing shares.
View analyst ratings for Absci
or view top-rated stocks.

What stocks does MarketBeat like better than Absci?

Wall Street analysts have given Absci a "Hold" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Absci wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Absci?

Absci saw a increase in short interest during the month of September. As of September 15th, there was short interest totaling 1,940,000 shares, an increase of 19.0% from the August 31st total of 1,630,000 shares. Based on an average trading volume of 419,400 shares, the short-interest ratio is currently 4.6 days. Approximately 3.3% of the shares of the stock are short sold.
View Absci's Short Interest

When is Absci's next earnings date?

Absci is scheduled to release its next quarterly earnings announcement on Tuesday, November 9th 2021.
View our earnings forecast for Absci

How can I listen to Absci's earnings call?

Absci will be holding an earnings conference call on Tuesday, November 9th at 8:30 AM Eastern. Interested parties can register for or listen to the call using this link.

How were Absci's earnings last quarter?

Absci Corp (NASDAQ:ABSI) released its quarterly earnings results on Monday, September, 6th. The company reported ($2.39) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.17) by $2.22. The business earned $0.73 million during the quarter, compared to the consensus estimate of $1.88 million.
View Absci's earnings history

What price target have analysts set for ABSI?

6 brokerages have issued 12-month target prices for Absci's shares. Their forecasts range from $26.00 to $40.00. On average, they expect Absci's stock price to reach $30.00 in the next year. This suggests a possible upside of 182.2% from the stock's current price.
View analysts' price targets for Absci
or view top-rated stocks among Wall Street analysts.

When did Absci IPO?

(ABSI) raised $200 million in an initial public offering on Thursday, July 22nd 2021. The company issued 12,500,000 shares at $15.00-$17.00 per share.

What is Absci's stock symbol?

Absci trades on the NASDAQ under the ticker symbol "ABSI."

When did the company's quiet period expire?

Absci's quiet period expired on Tuesday, August 31st. Absci had issued 12,500,000 shares in its initial public offering on July 22nd. The total size of the offering was $200,000,000 based on an initial share price of $16.00. During the company's quiet period, underwriters and any insiders that worked on the IPO were restricted from issuing any earnings forecasts or research reports for the company because of regulations issued by the Securities and Exchange Commission. Now that the company's quiet period has ended, brokerages that served as underwriters are now able to initiate research on the company.

How do I buy shares of Absci?

Shares of ABSI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Absci's stock price today?

One share of ABSI stock can currently be purchased for approximately $10.63.

How much money does Absci make?

Absci has a market capitalization of $983.88 million and generates $4.78 million in revenue each year.

What is Absci's official website?

The official website for Absci is www.absci.com.

How can I contact Absci?

The company can be reached via phone at 360-949-1041 or via email at [email protected].

This page was last updated on 10/17/2021 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.